ArticleScientific reports2026
Development and pilot evaluation of a binocular virtual reality Headset-Based pupillometer for quantitative assessment of pupillary light reflexes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Relative afferent pupillary defect (RAPD) is a key sign of optic neuropathies but is traditionally assessed subjectively. Virtual reality (VR) headsets with integrated binocular eye tracking enable simultaneous measurement under standardized illumination. We developed and conducted a pilot evaluation of a VR headset–based pupillometer that objectively quantifies RAPD using advanced pupil-tracking and automated blink-correction algorithms. This proof-of-concept study enrolled 17 patients with unilateral optic neuropathy (glaucomatous, traumatic, ischemic, or inflammatory) and 30 healthy controls. A VR headset (FOVE®, Tokyo, Japan) recorded binocular pupillary responses at 120 Hz under photopic (~ 130 lx) and scotopic (< 1 lx) conditions. Two protocols captured direct and consensual light reflexes and simulated the swinging flashlight test. Measured parameters included minimum and maximum diameters, constriction percentage, constriction/dilation velocities, and logarithmic RAPD scores. Receiver operating characteristic (ROC) analysis assessed diagnostic accuracy relative to clinical RAPD grading. Patients exhibited significantly reduced direct constriction (26.3% vs. 47.8%; p < 0.001), slower dilation velocity, and higher absolute RAPD scores (2.46 ± 2.00 vs. 0.27 ± 0.25 log units; p < 0.001) than controls. ROC analysis demonstrated an area under the curve (AUC) of 0.903 for the absolute RAPD score, corresponding to 87% sensitivity and 91% specificity. The VR headset–based pupillometer objectively quantified RAPD by simultaneously recording direct and consensual responses. Given its high diagnostic accuracy, portability, and ease of use, this study provides preliminary evidence supporting the feasibility of VR-based pupillometry as an objective, reproducible alternative to conventional subjective testing for evaluating optic neuropathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.